Company: DVAX
Filing Date: 2025-05-12
Form Type: DEFA14A
Source: 0000930413-25-001704
Chunk: 35

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-12
Form: DEFA14A
Chunk 35
---
 have any questions about how to vote your shares, please call the firm that is assisting us with the solicitation of proxies Gold Card Vote FOR the following nominees only: The Board strongly urges you to discard and NOT to vote using any white proxy card or white voting instruction form sent to you by Deep Track. Call: 1 - 800 - 322 - 2885 (toll - free from the U.S. and Canada) or +1 - 212 - 929 - 5500 from other countries. Email: DVAX@mackenziepartners.com © Copyright DYNAVAX 2025

ibdroot \ projects \ IBD - NY \ dilates2022 \ 698484_1 \ Presentations \ 24. 2025.02.XX Fight Deck \ FINAL - to share with Cooley \ Dynavax Investor Presentation (May - 2025)_Print.pptx Appendix 47 |

ibdroot \ projects \ IBD - NY \ dilates2022 \ 698484_1 \ Presentations \ 24. 2025.02.XX Fight Deck \ FINAL - to share with Cooley \ Dynavax Investor Presentation (May - 2025)_Print.pptx Dynavax’s Innovative Vaccines Protect Patients Across The Globe From Infectious Diseases © Copyright DYNAVAX 2025 With HEPLISAV - B, We Provide … 95% protection against hepatitis B, as shown in pivotal trials across multiple patient types Faster protection and an easier dosing profile compared to competitors With CpG 1018, We Have… Within Our Pipeline, We Strive To … Provide the world with a safer and more effective Shingles vaccine than Shingrix, the current standard Develop the first FDA - approved vaccine for Plague in partnership with the U.S. Department of Defense Provided protection during global COVID - 19 pandemic by partnering in 3+ COVID - 19 vaccines Enhanced efficacy in HEPLISAV - B and powered a pipeline of vaccine candidates Millions of Patients Served 1 commercial vaccine protecting patients worldwide 2+ clinical - stage programs for next - generation vaccines 3 partnerships leveraging CpG 1018 adjuvant technology 48 |

ibdroot \ projects \ IBD - NY \ dilates2022 \ 698484_1 \ Presentations \ 24. 2025.02.XX Fight Deck \ FINAL - to share with Cooley \ Dynavax Investor Presentation (May - 2025)_Print.pptx Source: Internal data and